NCT06932718 Smoking Cessation Programme in Workplaces in Hong Kong (Phase ⅤII)
| NCT ID | NCT06932718 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Hong Kong |
| Condition | Smoking Cessation |
| Study Type | INTERVENTIONAL |
| Enrollment | 328 participants |
| Start Date | 2025-03-18 |
| Primary Completion | 2026-12-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 328 participants in total. It began in 2025-03-18 with a primary completion date of 2026-12-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Smoking cessation (SC) interventions using behavioral economics mainly focus on financial incentives, which were used to change health behaviors by utilizing a reward system to enhance long-term maintenance. Incentives have been demonstrated to enhance SC across various populations with moderate effects. Interventions for smoking cessation characterized by financial incentives focus primarily on the potential for monetary gain rather than loss. Changing the motivational strategy to combine disclosing losses with providing financial incentives may increase the effectiveness of financial consequence-based smoking cessation interventions. Thus, this study aims to test, by a 2-arm RCT, the effectiveness of an intervention of which includes mobile phone-based intervention combined with small incentive and smoking cessation in workplaces in Hong Kong; identify facilitators and barriers of successful policy implementation and quitting; examine and evaluate the company environment and their policies in promoting smoking cessation.
Eligibility Criteria
Inclusion Criteria: 1. Hong Kong residents aged 18 or above 2. Current smoking cigarettes or alternative tobacco products daily with an exhaled carbon monoxide level ≥4 ppm or a positive salivary cotinine test 3. Able to communicate in Cantonese/Mandarin and read Chinese 4. Able to use instant messaging tool (e.g. WhatsApp) for communication. 5. Stay in Hong Kong during the intervention and follow-up periods (12 months) Exclusion Criteria: 1. Smokers who are psychologically or physically unable to communicate 2. Currently following other SC program(s) 3. Having used NRT for the past month 4. Having severe angina, serious cardiac arrhythmias and hypertension 5. Have acute myocardial event in the past month 6. Being pregnant or providing breastfeeding
Contact & Investigator
Man Ping Wang
PRINCIPAL INVESTIGATOR
The University of Hong Kong
Frequently Asked Questions
Who can join the NCT06932718 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Smoking Cessation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06932718 currently recruiting?
Yes, NCT06932718 is actively recruiting participants. Contact the research team at mpwang@hku.hk for enrollment information.
Where is the NCT06932718 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT06932718 clinical trial?
NCT06932718 is sponsored by The University of Hong Kong. The principal investigator is Man Ping Wang at The University of Hong Kong. The trial plans to enroll 328 participants.